| Size | Price | Stock | Qty |
|---|---|---|---|
| 50mg |
|
||
| 100mg |
|
||
| Other Sizes |
|
DOTA-NHS-ester is a novel and potent linker for affibody molecules. It is applied in small animals PET, SPECT, and CT. DOTA-NHS-ester can be used to label radiotherapeutic agents or imaging probes for the detection of tumors.
| ln Vitro |
DOTA-NHS-ester is capable of altering human serum albumin (HSA) to create DOTA-HSA. DOTA-HSA-SMCC was then created by further modifying DOTA-HSA with Sulfo-SMCC. The result of conjugating DOTA-HSA-SMCC with ZHER2:342 is DOTA-HSA-ZHER2:342[1]. 64Cu was added to DOTA-HSA-ZHER2:342 in the cellular uptake assay. 64Cu-DOTA-HSA-ZHER2:342 accumulated gradually in SKOV3 cells over the course of 0.5-2 hours, reaching 0.71% of the applied activity at 0.5 hours 2. At h, the rate of absorption rises to 1.58%[1].
|
|---|---|
| ln Vivo |
MicroPET pictures of mice with SKOV3 tumors were obtained after the mice's tail was injected with 64Cu-DOTA-HSA-ZHER2:342. Mice with SKOV3 tumors were imaged using microPET at 1, 4, 24, and 48 hours following tail vein injection. after one hour after injection (pi), SKOV3 tumors were evident with low tumor-to-background contrast; however, after four and twenty-four hours after injection, the tumor-to-background contrast was very good. SKOV3 tumor uptake values rose throughout time, according to quantitative analysis, reaching 5.63%, 9.98%, 14.34%, and 14.12% ID/g at 1, 4, 24, and 48 hours, respectively [1].
|
| References |
[1]. Hoppmann S, et al. Radiolabeled affibody-albumin bioconjugates for HER2-positive cancer targeting.Bioconjug Chem. 2011 Mar 16;22(3):413-2
|
| Molecular Formula |
C₂₀H₃₁N₅O₁₀
|
|---|---|
| Molecular Weight |
501.49
|
| CAS # |
170908-81-3
|
| Related CAS # |
DOTA-tris(tBu)ester NHS ester;819869-77-7
|
| Appearance |
Typically exists as solids (or liquids in special cases) at room temperature
|
| SMILES |
OC(CN1CCN(CC(=O)O)CCN(CC(ON2C(=O)CCC2=O)=O)CCN(CC(=O)O)CC1)=O
|
| Synonyms |
DOTANHSester DOTA NHS ester
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~50 mg/mL (~99.70 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (4.99 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (4.99 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (4.99 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.9941 mL | 9.9703 mL | 19.9406 mL | |
| 5 mM | 0.3988 mL | 1.9941 mL | 3.9881 mL | |
| 10 mM | 0.1994 mL | 0.9970 mL | 1.9941 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
